Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allison L Naleway

Showing results (161-170 of 235) with videos related to

Pageof 24
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 10, 2021
Comparison of the Immunogenicity of Cell Culture-Based and Recombinant Quadrivalent Influenza Vaccines to Conventional Egg-Based Quadrivalent Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized Open-Label TrialFatimah S Dawood, Allison L Naleway, Brendan Flannery, et al.
Vaccine|June 20, 2025
Recombinant quadrivalent influenza vaccine (RIV) induces robust cell-mediated and HA-specific B cell humoral immune responses among healthcare personnelMargarita Mishina, Weiping Cao, Zachary Ende, et al.
The Pediatric Infectious Disease Journal|February 14, 2025
Knowledge About Respiratory Syncytial Virus and Acceptance of Infant Monoclonal Antibody for RSV and RSV Vaccination During PregnancyJennifer L Kuntz, Tara M Babu, Leora R Feldstein, et al.
Pediatrics|May 5, 2025
Infant Respiratory Syncytial Virus Immunization Coverage in the Vaccine Safety Datalink: 2023-2024Stephanie A Irving, Bradley Crane, Eric S Weintraub, et al.
Microbiology Spectrum|June 6, 2022
Detection and Stability of SARS-CoV-2 in Three Self-Collected Specimen Types: Flocked Midturbinate Swab (MTS) in Viral Transport Media, Foam MTS, and SalivaVic Veguilla, Ashley L Fowlkes, Adam Bissonnette, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 16, 2023
Vaccine Effectiveness Against Pediatric Influenza-A-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2022-2023 Season: VISION NetworkKatherine Adams, Zachary A Weber, Duck-Hye Yang, et al.
Pediatrics|November 12, 2025
Effectiveness of 2023-2024 COVID-19 Vaccines in Children in the United StatesStephanie A Irving, Elizabeth A K Rowley, Sean Chickery, et al.
Plos One|December 31, 2024
Risk reduction in SARS-CoV-2 infection and reinfection conferred by humoral antibody levels among essential workers during Omicron predominanceJames Hollister, Cynthia Porter, Ryan Sprissler, et al.
Environmental Research|October 10, 2023
Serum per- and polyfluoroalkyl substance concentrations and longitudinal change in post-infection and post-vaccination SARS-CoV-2 antibodiesJames Hollister, Alberto J Caban-Martinez, Katherine D Ellingson, et al.
The Journal of Infection|April 22, 2026
INFLUENZA HOUSEHOLD TRANSMISSION AND GENOMIC DIVERSITY IN THE UNITED STATES: A PROSPECTIVE COHORT STUDY, 2022-2024Sarah N Cox, Julia C Bennett, Amanda M Casto, et al.
Pageof 24

Showing results (161-170 of 235) with videos related to

Sort By:
Pageof 24
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 10, 2021
Comparison of the Immunogenicity of Cell Culture-Based and Recombinant Quadrivalent Influenza Vaccines to Conventional Egg-Based Quadrivalent Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized Open-Label TrialFatimah S Dawood, Allison L Naleway, Brendan Flannery, et al.
Vaccine|June 20, 2025
Recombinant quadrivalent influenza vaccine (RIV) induces robust cell-mediated and HA-specific B cell humoral immune responses among healthcare personnelMargarita Mishina, Weiping Cao, Zachary Ende, et al.
The Pediatric Infectious Disease Journal|February 14, 2025
Knowledge About Respiratory Syncytial Virus and Acceptance of Infant Monoclonal Antibody for RSV and RSV Vaccination During PregnancyJennifer L Kuntz, Tara M Babu, Leora R Feldstein, et al.
Pediatrics|May 5, 2025
Infant Respiratory Syncytial Virus Immunization Coverage in the Vaccine Safety Datalink: 2023-2024Stephanie A Irving, Bradley Crane, Eric S Weintraub, et al.
Microbiology Spectrum|June 6, 2022
Detection and Stability of SARS-CoV-2 in Three Self-Collected Specimen Types: Flocked Midturbinate Swab (MTS) in Viral Transport Media, Foam MTS, and SalivaVic Veguilla, Ashley L Fowlkes, Adam Bissonnette, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 16, 2023
Vaccine Effectiveness Against Pediatric Influenza-A-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2022-2023 Season: VISION NetworkKatherine Adams, Zachary A Weber, Duck-Hye Yang, et al.
Pediatrics|November 12, 2025
Effectiveness of 2023-2024 COVID-19 Vaccines in Children in the United StatesStephanie A Irving, Elizabeth A K Rowley, Sean Chickery, et al.
Plos One|December 31, 2024
Risk reduction in SARS-CoV-2 infection and reinfection conferred by humoral antibody levels among essential workers during Omicron predominanceJames Hollister, Cynthia Porter, Ryan Sprissler, et al.
Environmental Research|October 10, 2023
Serum per- and polyfluoroalkyl substance concentrations and longitudinal change in post-infection and post-vaccination SARS-CoV-2 antibodiesJames Hollister, Alberto J Caban-Martinez, Katherine D Ellingson, et al.
The Journal of Infection|April 22, 2026
INFLUENZA HOUSEHOLD TRANSMISSION AND GENOMIC DIVERSITY IN THE UNITED STATES: A PROSPECTIVE COHORT STUDY, 2022-2024Sarah N Cox, Julia C Bennett, Amanda M Casto, et al.
Pageof 24